Preclinical studies of [61Cu]ATSM as a PET radiopharmaceutical for fibrosarcoma imaging

Acta Pharmaceutica

Volumn 59, Issue 1, 2009, Pages 45-55

  Jalilian, Amir R ^a   Rostampour, Nima ^b   Rowshanfarzad, Pejman ^a   Shafaii, Kamaleddin ^a   Kamali Dehghan, Mohsen ^a   Akhlaghi, Mehdi ^a  

^a AGRICULTURAL MEDICAL AND INDUSTRIAL RESEARCH SCHOOL   (Iran)

^b HAMADAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Copper 61; Fibrosarcoma; Imaging; Positron emission tomography; Radiopharmaceuticals; 61Cu ATSM hypoxia

Indexed keywords

ACETATE CU 61; ACETIC ACID DERIVATIVE; COPPER; COPPER 61; DIACETYL BIS(N4 METHYLTHIOSEMICARBAZONE) CU 61; THIOSEMICARBAZONE DERIVATIVE; TRACER; UNCLASSIFIED DRUG; ZINC CHLORIDE; COPPER (II) DIACETYL DI(N(4) METHYLTHIOSEMICARBAZONE); COPPER (II) DIACETYL-DI(N(4)-METHYLTHIOSEMICARBAZONE); DIAGNOSTIC AGENT; ORGANOMETALLIC COMPOUND; RADIOPHARMACEUTICAL AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG PURITY; DRUG QUALITY; DRUG STABILITY; DRUG STRUCTURE; FIBROSARCOMA; HUMAN; HYPOXIA; ION PAIR CHROMATOGRAPHY; MALE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; RAT; ANIMAL; CELL HYPOXIA; DRUG SCREENING; EXPERIMENTAL NEOPLASM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METHODOLOGY; THIN LAYER CHROMATOGRAPHY; TISSUE DISTRIBUTION;

ANIMALS; CELL HYPOXIA; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, THIN LAYER; COPPER RADIOISOTOPES; DRUG EVALUATION, PRECLINICAL; FIBROSARCOMA; MALE; NEOPLASMS, EXPERIMENTAL; ORGANOMETALLIC COMPOUNDS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RATS; THIOSEMICARBAZONES; TISSUE DISTRIBUTION;

EID: 62949118369     PISSN: 13300075     EISSN: None     Source Type: Journal    
DOI: 10.2478/v10007-009-0008-9     Document Type: Article

References (19)

1. 2 predicts survival in advanced cancer of the uterine cervix, Radiother. Oncol. 26 (1993) 45-50; DOI: 10.1016/0167-8140(93)90025-4.
2. P. J. Blower, J. S. Lewis and J. Zweit, Copper radionuclides and radiopharmaceuticals in nuclear medicine, J. Nucl. Med. Biol. 23 (1996) 957-980; DOI: 10.1016/S0969-8051(96)00130-8.
3. 62Cu-PTSM, J. Nucl. Med. 41 (2000) 309-314.
4. C. S. Cutler, J. S. Lewis and C. J. Anderson, Utilization of metabolic, transport and receptor-mediated processes to deliver agents for cancer diagnosis, Advan. Drug Deliv. Rev. 37 (1999) 189-211; DOI: 10.1016/S0169-409X(98)00093-3.
5. P. L. Jager, M. A. de Korte, M. N. Lub-de Hooge, A. van Waarde, K. P. Koopmans, P. J. Perik and E. G. de Vries, Molecular imaging: what can be used today, Cancer Imag. 23 (2005) A S27-S32; DOI: 10.1102/1470-7330. 2005.0023.
6. 61Cu from a natural nickel target, J. Appl. Radiat. Isot. 49 (1998) 79-81; DOI: 10.1016/S0969-8043(97)00235-2.
7. D. W. McCarthy, L. A. Bass, P. D. Cutler, R. E. Shefer, R. Klinkowstein, P. Herrero, J. S. Lewis, C. C. Cutler, C. J. Anderson and M. J. Welch, High purity production and potential applications of copper-60 and copper-61, Nucl. Med. Biol. 26 (1999) 351-358; DOI: 10.1016/S0969-8051(98) 00113-9.
8. J. S. Lewis, T. L. Sharp, R. Laforest, Y. Fujibayashi and M. J. Welch, Tumor uptake of copper-diacetyl-bis(N4-methylthiosemicarbazone): effect of changes in tissue oxygenation, J. Nucl. Med. 42 (2001) 655-661.
9. 60Cu-ATSM, Eur. J. Nucl. Med. Mol. Imag. 30 (2003) 844-840.
10. 61Cu] Diacetyl-bis(N4-methylthiosemicarbazone) for PET studies, J. Radioanal. Nucl. Chem. 269 (2006) 147-154; DOI: 10.1007/s10967-006-0244-0.
11. M. Blann and J. Bislinghoff, Code Alice/Livermore 91, Lawrence Livermore National Laboratory, Internal Report, UCID-19614 (1991) (a software).
12. J. F. Ziegler, J. P. Biersack and U. Littmark, The Code of SRIM the Stopping and Range of Ions in Matter, Version 2000.XX, (2000) (a software).
13. A. M. Weisberg, Gold Plating, 9th ed., ASM International, Metals Park 1990, p. 247.
14. 67Cu from irradiated zinc for use in antibody labelling: a comparison of methods, Appl. Rad. Isot. 46 (1995) 329-336; DOI: 10.1016/0969-8043(95) 00010-B.
15. Y. Ni, S. Chen and S. Kokot, Spectrophotometric determination of metal ions in electroplating solutions in the presence of EDTA with the aid of multivariate calibration and artificial neural networks, Anal. Chim. Acta 463 (2002) 2305-2316; DOI: 10.1016/S0003-2670(02)00437-3.
16. J. Zweit, R. Goodal, M. Cox, J. W. Babich, G. A. Potter, H. L. Sharma and R. J. Ott, Development of a high performance zinc-62/copper-62 radionuclide generator for positron emission tomography, Eur. J. Nucl. Med. 19 (1992) 418-425; DOI: 10.1007/BF00177368.
17. A. R. Jalilian, M. Sadeghi, Y. Yari-Kamrani and M. R. Ensaf, Development of [103Pd]-2-acetylpyridine 4N-methyl thiosemicarbazone complex for targeted therapy, J. Rad. Nucl. Chem. 268 (2006) 605-611; DOI: 10.1007/s10967-006-0212-8.
18. 64Cu-labeled monocationic copper(II) complex, Nucl. Med. Biol. 29 (2002) 289-294; DOI: 10.1016/S0969-8051(02)00285-8.
19. K. J. Greenlee, Z. Werb and F. Kheradmand, Matrix metalloproteinases in lung: multiple, multifarious, and multifaceted, Physiol. Rev. 87 (2007) 69-98; DOI: 10.1152/physrev.00022.2006.